- Home
- NWBI vs IDYA Comparison
NWBI vs IDYA Comparison
Compare NWBI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWBI
- IDYA
- Stock Information
- Founded
- NWBI 1896
- IDYA 2015
- Country
- NWBI United States
- IDYA United States
- Employees
- NWBI 2099
- IDYA N/A
- Industry
- NWBI Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- NWBI Finance
- IDYA Health Care
- Exchange
- NWBI Nasdaq
- IDYA Nasdaq
- Market Cap
- NWBI 1.8B
- IDYA 2.1B
- IPO Year
- NWBI N/A
- IDYA 2019
- Fundamental
- Price
- NWBI $12.66
- IDYA $24.25
- Analyst Decision
- NWBI Hold
- IDYA Strong Buy
- Analyst Count
- NWBI 1
- IDYA 13
- Target Price
- NWBI $15.00
- IDYA $51.36
- AVG Volume (30 Days)
- NWBI 918.3K
- IDYA 856.9K
- Earning Date
- NWBI 10-28-2025
- IDYA 08-05-2025
- Dividend Yield
- NWBI 6.33%
- IDYA N/A
- EPS Growth
- NWBI 39.35
- IDYA N/A
- EPS
- NWBI 1.12
- IDYA N/A
- Revenue
- NWBI $561,855,000.00
- IDYA $7,000,000.00
- Revenue This Year
- NWBI $7.67
- IDYA $62.30
- Revenue Next Year
- NWBI $16.05
- IDYA $285.58
- P/E Ratio
- NWBI $11.28
- IDYA N/A
- Revenue Growth
- NWBI 14.22
- IDYA N/A
- 52 Week Low
- NWBI $10.75
- IDYA $13.45
- 52 Week High
- NWBI $15.42
- IDYA $40.25
- Technical
- Relative Strength Index (RSI)
- NWBI 57.97
- IDYA 59.45
- Support Level
- NWBI $12.57
- IDYA $24.42
- Resistance Level
- NWBI $12.77
- IDYA $25.63
- Average True Range (ATR)
- NWBI 0.23
- IDYA 0.84
- MACD
- NWBI 0.11
- IDYA 0.03
- Stochastic Oscillator
- NWBI 90.91
- IDYA 84.62
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.